Skip to Main Content

Paper Details

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib.
Clin Cancer Res
7
2020
Author NameAffiliation
Meredith M ReganDana-Farber Cancer Institute
Mary-Ellen TaplinLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Mark M PomerantzLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Mark M PomerantzLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2